18 major players in the global spine biologics market

The global spine biologics market is predicted to reach $2.7 billion by 2024, growing at a 4.4 percent compound annual growth rate, according to a Data Bridge Market Research report.

Advertisement
By: Staff

Here are 18 major market players:

1. Arthrex

2. Cesca Therapeutics

3. DePuy Synthes

4. DMP Spine

5. Exactech

6. K2M

7. Lattice Biologics

8. Medtronic

9. Nuo Therapeutics

10. Nutech

11. NuVasive

12. Orthofix

13. Regen Lab

14. RTI Surgical

15. Stryker

16. Wright Medical

17. X-Spine Systems

18. Zimmer Holdings

More articles on biologics:
Crocodiles may be the future of cartilage repair — 4 things to know about a new technology
UC San Diego scientists derive spinal cord stem cells: 4 insights
Dr. Kevin Pauza certifies 14 spine physicians in Discseel procedure

Capacity crises are coming: How 5 health systems are getting ahead

Recommended Whitepaper

Advertisement

Next Up in Biologics

Advertisement

Comments are closed.